Author:
Milone G,Leotta S,Indelicato F,Mercurio S,Moschetti G,Di Raimondo F,Tornello A,Consoli U,Guido G,Giustolisi R
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference31 articles.
1. To LB, Roberts MM, Haylock DN et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 1992; 9: 277–284.
2. Schmitz N, Linch DC, Dreger P et al. Randomized trial of filgrastim-mobilized peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 1996; 347: 353–357.
3. Alegre A, Tomas JF, Martinez-Chomorro C et al. Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high dose cyclophosphamide plus GM-CSF vs G-CSF alone. Bone Marrow Transplant 1997; 20: 211–217.
4. Desikan KR, Barlogie B, Jagannath S et al. Comparable engraftment kinetics following peripheral blood stem cell infusion mobilized with granulocyte colony stimulating factor with or without cyclophosphamide in multiple myeloma. J Clin Oncol 1998; 6: 1547–1553.
5. Akard LP, Thompson JM, Dugan MJ et al. Matched pair analysis of hemopoietic progenitor cell mobilisation using G-CSF vs cyclophosphamyde, etoposide and G-CSF in enhanced CD34+ cell collections are not necessarily cost-effective. Biol Blood Marrow Transplant 1999; 5: 379–385.
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献